324 related articles for article (PubMed ID: 26272522)
1. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.
Tung R; Bauer B; Schelbert H; Lynch JP; Auerbach M; Gupta P; Schiepers C; Chan S; Ferris J; Barrio M; Ajijola O; Bradfield J; Shivkumar K
Heart Rhythm; 2015 Dec; 12(12):2488-98. PubMed ID: 26272522
[TBL] [Abstract][Full Text] [Related]
2. Detection of inflammation using cardiac positron emission tomography for evaluation of ventricular arrhythmias: An institutional experience.
Hayase J; Do DH; Liang JJ; Kim M; Lee B; Ajijola O; Buch E; Boyle N; Shivkumar K; Bradfield JS
Heart Rhythm; 2022 Dec; 19(12):2064-2072. PubMed ID: 35932988
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of fluorine-18 fluoro-2-deoxyglucose positron emission computed tomography in patients with unexplained atrioventricular block.
Danwade TA; Devidutta S; Shelke AB; Saggu DK; Yalagudri SD; Sridevi C; Reddy NK; Narasimhan C
Heart Rhythm; 2018 Feb; 15(2):234-239. PubMed ID: 29061522
[TBL] [Abstract][Full Text] [Related]
4. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
5. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of PET in Assessing Ventricular Arrhythmias.
Muser D; Castro SA; Alavi A; Santangeli P
PET Clin; 2019 Apr; 14(2):281-291. PubMed ID: 30826025
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of
Protonotarios A; Wicks E; Ashworth M; Stephenson E; Guttmann O; Savvatis K; Sekhri N; Mohiddin SA; Syrris P; Menezes L; Elliott P
Int J Cardiol; 2019 Jun; 284():99-104. PubMed ID: 30409737
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
9. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
10. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
[TBL] [Abstract][Full Text] [Related]
12. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
13. Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.
Farquharson AL; Chopra A; Ford A; Matthews S; Amin SN; De Noronha R
Colorectal Dis; 2012 Feb; 14(2):e56-63. PubMed ID: 21831171
[TBL] [Abstract][Full Text] [Related]
14. Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse.
Miller MA; Adams DH; Pandis D; Robson PM; Pawale A; Pyzik R; Liao SL; El-Eshmawi A; Boateng P; Garg J; Waterford S; Weiner MM; Dukkipati SR; Reddy VY; Fayad ZA; Trivieri MG
JAMA Cardiol; 2020 Sep; 5(9):1000-1005. PubMed ID: 32936270
[TBL] [Abstract][Full Text] [Related]
15. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
[TBL] [Abstract][Full Text] [Related]
16. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
18. 18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular Cardiomyopathy.
Tessier R; Marteau L; Vivien M; Guyomarch B; Thollet A; Fellah I; Jamet B; Sébille JC; Eugene T; Serfaty JM; Probst V; Trochu JN; Toquet C; Warin-Fresse K; Piriou N
Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014065. PubMed ID: 35770631
[No Abstract] [Full Text] [Related]
19. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]